AnPac Bio: Jumps after Q1 cancer test volumes more than doubles

Fresh2

19/04/2021 15:24

** U.S.-listed shares of Chinese biotech co AnPac
Bio-Medical Science Co  ANPC.O  jump 4.4% to $5.22 
    ** ANPC says Q1 cancer differentiation analysis technology
(CDA)-based test volumes rose 130%  urn:newsml:reuters.com:*:nGNX4bbg7z
    ** Co's CDA-based tests are multi-cancer tests based on a
novel biophysical approach; co says paid CDA-based tests had the
highest volumes among all its tests in the quarter
    ** ANPC had fallen 5.6% YTD, as of last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))